Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: A potential pathway to cancer?

Helicobacter

Volumn 8, Issue 3, 2003, Pages 227-234

  Farinati, Fabio ^a,b   Cardin, Romilda ^a   Russo, Valentina M ^a   Busatto, Graziella ^b   Franco, Monica ^a   Rugge, Massimo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CAGA PROTEIN;

ADULT; AGED; ARTICLE; ATROPHY; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DNA DAMAGE; ENDOSCOPY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INFLAMMATION; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; OXIDATIVE STRESS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCORING SYSTEM; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CANCER;

AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DEOXYGUANOSINE; DNA ADDUCTS; DNA DAMAGE; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; OXIDATIVE STRESS; PHENOTYPE; REGRESSION ANALYSIS; STOMACH NEOPLASMS;

HELICOBACTER; HELICOBACTER PYLORI; INCISURA;

EID: 0037844422     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.2003.00149.x     Document Type: Article

References (42)

1. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;87:1777-80.
2. Figueiredo C, Van Doorn LJ, Nogueira C, et al. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol 2001;36:128-35.
3. Miehlke S, Yu J, Schuppler M, Frings C, et al. Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease. Am J Gastroenterol 2001;96:1008-13.
4. Nogueira C, Figueiredo C, Carneiro F, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001;158:647-54.
5. Peek RM Jr, Blaser MJ, Mays DJ, et al. Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res 1999;59:6124-31.
6. Moss SF, Sordillo EM, Abdalla AM, et al. Increased gastric epithelial cell apoptosis associated with colonization with cagA+ Helicobacter pylori strains. Cancer Res 2001;61:1406-11.
7. Kidd M, Lastovica AJ, Atherton JC, Louw JA. Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in south Africa? Gut 1999;45:499-02.
8. Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specific Helicobacter pylori antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996;91:1785-8.
9. Yamaoka Y, Kodama T, Kashima K, Graham DY. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol 1999;52:215-8.
10. Kurihara N, Kamiya S, Yamaguchi H, et al. Characteristics of Helicobacter pylori strains isolated from patients with different gastric disease. J Gastroenterol 1998;33:10-3.
11. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Saito Y, Munakata A. High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scand J Gastroenterol 1997;32:465-8.
12. Graham DY, Yamaoka Y. Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter 2000;5:S27-31.
13. Mathew A, Gangadharan P, Varghese C, Nair MK. Diet and stomach cancer: a case-control study in South India. Eur J Cancer Prev 2000;9:89-97.
14. Ando T, Peek RM Jr, Lee YC, Krishna U, Kusugami K, Blaser MJ. Host cell responses to genotypically similar Helicobacter pylori isolates from United States and Japan. Clin Diagn Laboratory Immunol 2002;9:167-75.
15. Rugge M, Busatto G, Cassaro M, et al. Patients younger than 40 years with gastric carcinoma. Helicobacter pylori genotype and associated gastritis phenotype. Cancer 1999;85:2506-11.
16. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999;37:2274-9.
17. Baik SC, Youn HS, Chung MH, et al. Increased oxidative DNA damage in Helicobacter pylori infected human gastric mucosa. Cancer Res 1996;56:1279-82.
18. Danese S, Cremonini F, Armuzzi A, et al. Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa. Scand J Gastroenterol 2001;36:247-50.
19. Farinati F, Cardin R, Degan P, et al. Oxidative DNA damage accumulation in gastric carcinogenesis. Gut 1998;42:351-6.
20. Kuchino Y, Mori F, Kasai H, et al. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 1987;327:77-9.
21. Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002 July;16:1249-59.
22. Genta RM. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol 1996;20:S23-30.
23. Shiao YH, Rugge M, Correa P, Lehmann HP, Scheer WD. P53 alteration in gastric precancerous lesions. Am J Pathol 1994;144:511-7.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual, 2nd edn. New York, USA: Cold Spring Harbor 1989.
25. Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN. Oxidative damage to DNA during aging. 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990;87:4533-7.
26. Crabtree JE. Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol Suppl 1996;21:3-10.
27. Go MF. Review article natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16:3-15.
28. Palli D, Menegatti M, Masala G, et al. Helicobacter pyloi infection, anti-cagA antibodies and peptic ulcer: a case-control study in Italy. Aliment Pharmacol Ther 2002;16:1015-20.
29. Figura N, Valassina M, Roviello F, et al. Helicobacter pylori cagA and vacA types and gastric carcinoma. Digest Liver Dis 2000;32:S182-3.
30. Farinati F, Della Libera G, Cardin R, et al. Gastric antioxidant, nitrites, and mucosal lipoperoxidation in chronic gastritis and Helicobacter pylori infection. J Clin Gastroenterol 1996;22:275-81.
31. You WC, Blot WJ, Li JY, et al. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res 1993;53:1317-21.
32. Xia HH, Kalantar JS, Talley NJ, et al. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol 2000;95:114-21.
33. Rudi J, Kolb C, Maiwald M, et al. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci 1997; 42:1652-9.
34. Pignatelli B, Bancel B, Plummer M, Toyokuni S, Patricot LM, Oshima H. Helicobacter pylori eradication attenuates oxidative stress in human gastric mucosa. Am J Gastroenterol 2001;96:1759-66.
35. Valle J, Gisbert JP. Helicobacter pylori infection and precancerous lesions of the stomach. Hepatogastroenterology 2001;48:1548-51.
36. Meining A, Morgner A, Miehlke S, Bayerdorffer E, Stolte M. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract Res Clin Gastroenterol 2001;15:983-98.
37. Annibale B, Di Giulio E, Caruana P, et al. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment Pharmacol Ther 2002;16:1723-31.
38. Sipponen P. Update on the pathologic approach to the diagnosis of gastritis, gastric atrophy, and Helicobacter pylori and its sequelae. J Clin Gastroenterol 2001;32:196-02.
39. Ernst P. Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol 1999;13:13-8.
40. Papa A, Danese S, Sgambato A, et al. Role of Helicobacter pylori CagA+ infection in determining oxidative DNA damage in gastric mucosa. Scand J Gastroenterol 2002;37:409-13.
41. Zhang QB, Nakashabendi IM, Mokhashi MS, Dawodu JB, Gemmell CG, Russell RI. Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut 1996;38:841-5.
42. Maaroos HI, Vorobjova T, Sipponen P, et al. An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis. Scand J Gastroenterol 1999;34:864-9.